| Nature 432, 29 (04 November 2004); doi:10.1038/432029a |
|
|
AMANDA TROMANS
Using mice, the authors first discovered that the protein in question, named
Baf60c, is initially expressed only in the developing heart. Investigating
further, they found that completely eliminating Baf60c from mouse embryos led to
major cardiac defects (and early death). Knocking out about 50% of the protein
led to somewhat milder, although still ultimately fatal, problems, such as an
abnormally straight and split outflow tract (the yellow area in this
picture). Why do these problems occur? Baf60c is part of a complex that controls the
accessibility of genes by interacting with transcription factors — proteins that
regulate gene expression. So perhaps,without Baf60c, heart-specific genes cannot
gain access to the transcriptional machinery and therefore remain inactive.
Indeed, Bruneau and colleagues found that many genes that are characteristic of
different aspects of heart development are not expressed when Baf60c is
eliminated, including various genes involved in the formation of the outflow
tract. Moreover, in in vitro studies, the authors showed that Baf60c
enhances the interaction between Brg1, a key component of the complex in which
Baf60c is found, and certain heart-specific transcription factors. So, at early stages of development, Baf60c seems to ensure that a complex
that alters the structure of DNA — and hence its accessibility to proteins that
activate genes — is targeted specifically to genes that are needed for heart
development. This mechanism might also work in other tissues, with proteins
other than Baf60c providing the necessary specificity. And the findings might
bear on human disease: the defects caused by a partial lack of Baf60c are
somewhat similar to those seen in some people with congenital heart defects. It
remains to be seen, however, how the heart-specific expression of Baf60c is
achieved in the first place.
Embryonic development is largely a matter of
switching on the right genes, in the right place, and at the right time — it's
no use activating heart-manufacturing genes in the limbs, for instance.
Elsewhere in this issue (Nature 432, 107–112; 2004), Benoit G. Bruneau and
colleagues describe a protein that keeps heart-specific genes in their
place.
J. R.
WALLS 